Welcome to the July  issue of News Across Latin America, the quarterly publication for the ISPOR Latin America Consortium.

Thank you for your participation in ISPOR Virtual 2020. This is the first time the Society presented a completely virtual conference. With more than 1300 attendees from 54 different countries, the Latin America region was well represented. We were glad to see a good participation of delegates from Brazil, Mexico and Colombia forming the top 3 countries by number of attendees from the region. Thank you again for your support and for your contributions to make another ISPOR conference successful!   

This July issue brings to you the latest news on HEOR, health policy, and other relevant related topics. This issue also includes 2 articles:

In addition, we thank you for your participation in the Virtual ISPOR Latin America Consortia meeting -the summary reports of each country are included in this issue. If you would like to participate and contribute to advancing the HEOR science in Latin America, you can join us by sending an email to: laconsortium@ispor.org

We hope you enjoy this edition. As always, we welcome your comments and thoughts.  Please feel free to share this issue with your colleagues and contacts.


ISPOR News Across Latin America Team

Table of Contents:

| Regional News

| Featuring articles

| ISPOR Latin America News

| ISPOR Headquarter News

| About ISPOR Global Networks

|  Regional News:


“Ultimos avances en Argentina” – July 2020


“Brazil: A Major epicenter of the COVID-19 pandemic” – July 2020

  • COVID-19: Comienzan ensayos en Brasil con Vacuna de Oxford – Brasil ha sido el primer país fuera del Reino Unido en comenzar ensayos para la vacuna desarrollada por la institución británica. Se espera contar con al menos 20,000 pacientes voluntarios, tan solo en Sao Paulo y unos mil más en Rio de Janeiro para realizar estas pruebas. Las pruebas serán conducidas por el Centro de Referencia para Inmunobiológicos Especiales (CRIE) y contara con el apoyo financiero de la fundación Lemann.

Referencia: https://fundacaolemann.org.br/


“Situación de la Pandemia Coronavirus en Chile” – July 2020


“Epidemiologia de las Pandemias” – July 2020

Costa Rica:

“Evolución COVID-19 en Costa Rica: medidas sanitarias vs impacto económico (al 06 de julio 2020)” – July 2020


“Utlimos avances COVID-19 en Mexico” -July 2020


“El Contexto Uruguayo” – July 2020


“El panorama Venezolano” – July 2020

Value in Health Regional Issues Latin America

ISPOR Publications are now more accessible, searchable, and citable to researchers around the world! – for guidance on manuscript submissions to Value in Health Regional Issues, click here to learn more!

Related articles:

Adaptation and Validation of the Health Belief Model Scale for Breast Self-Examination in Mexican Women

Dehisy Marisol Juárez-García, Manuel de Jesús García-Solís, Arnoldo Téllez

Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making?

Carlos Castañeda-Orjuela, Mario García-Molina, Fernando De la Hoz-Restrepo

Implementing Health Technology Assessments in Latin America: Looking at the Past, Mirroring the Future. A Perspective from the ISPOR Health Technology Assessment Roundtable in Latin America

Ramiro E. Gilardino, Aurelio Mejía, Diego Guarín, Lucila Rey-Ares, Ana Perez

Para ver más artículos de clic aquí. Tenga en cuenta que la membresía de ISPOR es necesaria para acceder al artículo completo.

| ISPOR Latin America News:

Key Member Information

Welcome to the ISPOR Latin America Consortium 2020-2022 Leadership!

  • Executive Committee: Yajaira Bastardo, PhD, Chair, Professor of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy Central University of Venezuela, Caracas, Venezuela and Cesar Cruz, MD, PhD, Chair-Elect, General Health Council, Mexico.
  • Health Technology Producers (Industry) Committee: Homero Monsanto, PharmD, MSc, PhD, Chair, Executive Director, CORE Latin America, U.S.A, and Claudia Soares, MD, MPH, PhD, MSBI, Chair-Elect, RWE, Value & Access Sr. Director Emerging Markets Global Medical, Brazil.
  • Publications Committee: Herman Soto Molina, MSc, Chair – Director, H S Estudios Farmacoeconómicos SA de CV, México and Laura Cortés Sanabria, PhD, Chair-Elect, Unidad de Investigación Biomédica “02”, UMAE-Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, México.

Special recognition to our past chairs for their extraordinary leadership and service in the 2018-2020 period. Thank you for your support and dedication!

Upcoming Webinars to All Members and Non-Members

  •  Chapter Leader Training 2020 Announced – These interactive trainings are designed for ISPOR Regional Chapter and ISPOR Consortium leaders to support capacity building and leadership development. The trainings provide information on recent trends related to HEOR methodology or health policy, and they also equip ISPOR leaders with techniques to be successful in their ISPOR leadership roles.

Scheduled trainings:

  • La visión del Líder: Medicina Basada en Valor y la formación en Liderazgo – April 28, 2020. 9:00 AM EST. Presented in Spanish. – Click here to see the recorded webinar
  • Role of Digital Therapeutics in Reshaping the Future of Healthcare – July 15, 2020. 8:00 am EST. A link to the recorded webinar will be made available shortly on Chapter Leadership training webinar webpage.
  • To be announced soon – December 2020
  • Patient Reported Outcomes in Asia Pacific: Opportunity and Challenges – August 3, 2020. 8:15 AM EDT. The webinar will be held on 3 August and is hosted by the Asia Consortium. Speakers from Japan, Taiwan, and Hong Kong will discuss the importance, strengths, and limitations of patient-reported outcomes. Register here.
  • The Usage of Real-World Evidence (RWE): Monitoring and Managing Health Technologies in Latin America – Where We Are and Where We Are Heading. August 10, 2020 | 2:00PM EDT | 7:00PM GMT | 8:00PM CEST. This webinar will describe the Latin American trends in the use of RWE, and outline the current stage, challenges, and opportunities for the use of it in the regional decision-making process as well as describe the technical challenges for RWE from both global and regional perspectives. Register here.
  • Currently available, is the on-demand recording of the pre-Summit webinar, “Patient-Preference Information: What It Is and What It Is Not,” held on March 4. This educational event provided background information on patient-preference information—which will be useful, but not required—for Summit attendance. You can view the free webinar here and access the PDF slide deck here.  Please note that the webinar is free, but registration is required.
  • The Global Network team will be holding a joint webinar entitled “Global Experiences with the Use of HTA for Health Benefit Packages Development” August 26, 2020 | 8:00AM-9:15AM EDT Expert speakers from the regions of Latin America, Asia-Pacific and EMEA will discuss the role of HTA in UHC including priority setting, coverage and financing. They will also share their experience in effective application of HTA to support designing a benefits package for UHC while tackling the encountered challenges. Register here.
  • Sponsored Webinars – Use the power of ISPOR’s research to bring your message directly to the global HEOR community. ISPOR’s sponsored webinars provide a unique opportunity to reach and educate a targeted audience of HEOR researchers and decision makers. For more information contact Sean Gormley, Associate Director, Exhibits and Meeting Partnerships at: sgormley@ispor.org
  • If your Chapter is planning a regional event and an ISPOR Chapter logo will be placed on promotional materials, please make sure to contact laconsortium@ispor.org to request the ISPOR Regional Chapter logo! The branded logos for ISPOR Regional Chapters have been designed to identify the group’s relationship with ISPOR and provide a professional image to the group that is reflective of ISPOR’s brand, mission, and vision. The logo of the Society cannot be used for local activities organized by the Chapters!

| ISPOR Headquarter news:

  • ISPOR Asia Pacific 2020 Goes Virtual | 14-16 September – The Virtual ISPOR Asia Pacific 2020 event is specially designed for the Asia Pacific region and time zones. The conference, “Next Generation Healthcare in Asia Pacific: Where Technology Meets Patients to Improve Care,” will explore the impact of COVID-19 on the region, the role of HEOR in precision medicine, and patient access to high-cost interventions. Additional information and updates can be found on the website
  • ISPOR-FDA Summit 2020 Is Now Virtual | September 29– The ISPOR-FDA Summit 2020 has been rescheduled for September 29 as a virtual event. The Summit, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond,” is jointly sponsored by ISPOR and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH). Registration is complimentary.

ISPOR Short Course Program Is Now Virtual!

The ISPOR Short Course Program is now virtual and offering a number of high-interest HEOR courses in July.

  • July 27, 2020 | New: Introduction to Machine Learning Methods
  • July 30, 2020 | Causal Inference and Causal Diagrams in Big, Real-World Observational Data and Pragmatic Trials

            For more information and to register go here.

  • Join us at ISPOR Europe 2020! ISPOR Europe 2020 is being redesigned as a virtual conference. The full conference program will be announced soon. Virtual ISPOR Europe 2020 themed Improving Health: Establishing Incentives and Sharing Value,” where the questions of fundamental conventions around value, risk, rewards, and the role of public and private sectors, in the shadow of a global pandemic will be explored. Participate in transforming healthcare decision making. Register here.
  • Call for Member Contributions to COVID-19 News Page ISPOR’s COVID-19 News aggregates a selection of related content of interest to HEOR professionals and others in healthcare, and we encourage members to submit their news and ongoing research activities related to COVID-19.

New ISPOR Special Interest Group Reports:

  • New Definition of Health Technology Assessment – ISPOR participated in the development of the new HTA definition through an international collaboration co-led by INAHTA and HTAi with HTAsiaLink, EUnetHTA, RedETSA, ISPOR English Editorial Board of the HTA Glossary, and the WHO. To read the definition, click here. To read the full paper, click here.
  • New Task Force Initiated: Joint HTAi ISPOR Deliberative Processes for HTA Good Practices Task Force -ISPOR is collaborating with HTAi, a global, non-profit, scientific and professional society with HTA expertise and experience to address a gap in global decision making. The task force’s goal is to develop a consensus definition for a deliberative process from an HTA perspective and internationally recognized good practice recommendations on the use of deliberative processes in HTA. For more information, visit the task force webpage.

Dialogue with Decision Makers

  • Virtual ISPOR 18th Patient Representatives Roundtable – North America – The ISPOR Patient Representatives Roundtable-North America convened on June 15 to discuss incorporating patient-generated health data (PGHD) to inform healthcare decision making related to health technology assessment (HTA), value assessment, pricing, coverage, and reimbursement decisions. More than 45 representatives from various patient organizations, payers and HTA bodies, research organizations, government, and the pharmaceutical industry shared their perspectives including the Arthritis Foundation, Sick Cells, Blue Cross Blue Shield Association, ICER and US FDA. For more information, click here.
  • Virtual ISPOR 49th HTA-Pharmacy & Therapeutics (P&T) Roundtable – North AmericaRepresentatives from CADTH, ICER, various US health insurers, and many other organizations involved in HTA across North America met on June 23 to discuss the challenges and opportunities related to COVID-19. Discussion focused on the increase in expedited regulatory approvals, ultra-rapid reviews, and the impact this has on the healthcare system. This same group of stakeholders will meet on July 23 for the second part of the HTA Roundtable to discuss the management of digital therapeutics. For more information, click here.
  • The Health Science Policy Council advises the Board of Directors on key research issues in the field of health economics and outcomes research. The council is made up of past presidents, Avedis Donabedian award winners, HEOR experts, and other ISPOR council and consortium chairs. ISPOR is now looking to include 3 mid-career members with demonstrated contributions to both HEOR and ISPOR. If you are interested in joining this esteemed council for a term lasting until mid-2022, are a current ISPOR member, and have 6-14 years of experience in the HEOR field, please click here

There is more!

To learn about the latest HEOR news in (Asia Pacific / EMEA) and read about activities and initiatives of ISPOR global groups in the (Asia Pacific / EMEA) regions, please access the July 2020 issues of News Across Asia-Pacific  / July 2020 issue of News Across EMEA.

ISPOR News Across provides a valuable platform for information sharing for readers and advertisers alike. The ISPOR News Across editions are highly read by our ISPOR members and key opinion leaders globally, and there are opportunities to participate by advertising digitally in these publications in 2 different formats – 1) a horizontal banner (600×180 pixels) at $800, or 2) a small rectangle (300×250 pixels) at $500. Please contact laconsortium@ispor.org for more information.


The ISPOR Latin America Consortium is comprised of professionals interested in promoting health economics and outcomes research (HEOR) excellence to improve healthcare decision making in Latin America and globally. The Latin America consortium provides a platform for information-sharing and institutional collaboration on HEOR and health policy, facilitating professional networking opportunities through scientific activities and global ISPOR initiatives.

Have any questions or comments? laconsortium@ispor.org